Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Fritz Roth
Dana Farber Cancer Inst, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
SeqWell, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Roth is a member of the SeqWell, Inc Scientific Advisory Board for which he received a stock grant valued at (b)(4) of shares. In addition, Dr. Roth's loan to the company has been converted to a (b)(4) equity stake in the company. In total he has (b)(4) equity in the private company.
Dr. Roth's lab has engaged SeqWell for their sequencing services in the context of this grant. SeqWell provides SWIMSeq and KiloSeq services. Dr. Roth reported that these services are not commercially available elsewhere, and represent a far less expensive alternative to long-read sequencing by Sanger methods at the scale of thousands of clones.
Genomic Analysis of Network Perturbations in Human Disease
New information that will emerge from the proposed work should lead to a better understanding of the molecular mechanisms involved in human disease. We propose to improve our understanding of human disease by analyzing how disease-causing mutations relate to network perturbations. An important outcome of this work will be methods and approaches that can better established causality associated with mutations in disease genes and mechanistic insights that can better direct therapeutic intervention.
Filed on February 13, 2017.
Tell us what you know about Fritz Roth's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Fritz Roth”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Fritz Roth | Dana Farber Cancer Inst | Conflict of Interest | Ranomics, Inc. | Value cannot be readily determined |
| Fritz Roth | Dana Farber Cancer Inst | Conflict of Interest | Ranomics, Inc. | Value cannot be readily determined |
| Fritz Roth | Dana Farber Cancer Inst | Conflict of Interest | Ranomics, Inc. | Value cannot be readily determined |
| Fritz Roth | Dana Farber Cancer Inst | Conflict of Interest | Ranomics, Inc. | Value cannot be readily determined |
| Fritz Roth | Dana Farber Cancer Inst | Conflict of Interest | SeqWell, Inc. | Value cannot be readily determined |
| Fritz Roth | Dana Farber Cancer Inst | Conflict of Interest | SeqWell, Inc. | Value cannot be readily determined |
| Fritz Roth | Dana Farber Cancer Inst | Conflict of Interest | SeqWell, Inc. | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.